University of Michigan School of Nursing, Ann Arbor, MI.
University of Florida College of Public Health and Health Professions, Gainesville, FL.
JCO Oncol Pract. 2022 Sep;18(9):614-632. doi: 10.1200/OP.21.00863. Epub 2022 Jun 7.
To address health disparities faced by Black patients with cancer, it is critical that researchers conducting cancer clinical trials (CCTs) equitably recruit and retain Black participants, develop strategies toward this aim, and document associated outcomes. This narrative scoping literature review, as part of a larger study, aimed to identify, describe, and categorize strategies and interventions intended to improve the recruitment and retention of Black participants with breast, lung, prostate, colorectal, or multiple myeloma cancer into CCTs. We conducted comprehensive searches in PubMed, Embase, Cochrane Library, PsycInfo, CINAHL, Scopus, and Web of Science with three main concepts: Black persons, neoplasms, and clinical trial recruitment. The search resulted in 1,506 articles, of which 15 met inclusion criteria. Five main categories of recruitment and retention strategies and interventions were identified based on their specific population focus and type of approach: (1) participant identification, (2) provider awareness/resources, (3) focused research staff interventions, (4) patient and community-focused awareness strategies, and (5) participant-directed resources. Thirteen studies had recruitment acceptance rates of over 30%. Eight studies with acceptance rates of ≥ 50% reported implementing ≥ 5 strategies, with an average use of seven strategies across multiple categories. Five studies with acceptance rates ≥ 50% implemented strategies in ≥ 3 categories. Four studies reported retention rates ≥ 74%. Three studies with reported retention rates ≥ 74% used strategies in ≥ 3 categories, and all included strategies aimed at meeting participant needs beyond the study. Our results show that many efforts that aim to increase the recruitment and retention of Black participants into CCTs have great potential, but the most promising strategies use a multiprong approach.
为了解决癌症黑人患者面临的健康差距问题,进行癌症临床试验(CCT)的研究人员必须公平地招募和留住黑人参与者,为此制定策略,并记录相关结果。作为一项更大研究的一部分,本叙事范围文献综述旨在确定、描述和分类旨在提高乳腺癌、肺癌、前列腺癌、结直肠癌或多发性骨髓瘤黑人参与者入组 CCT 的招募和保留的策略和干预措施。我们在 PubMed、Embase、Cochrane 图书馆、PsycInfo、CINAHL、Scopus 和 Web of Science 中进行了全面检索,使用了三个主要概念:黑人、肿瘤和临床试验招募。搜索结果产生了 1506 篇文章,其中 15 篇符合纳入标准。根据其特定的人群重点和方法类型,确定了 5 种主要的招募和保留策略和干预措施类别:(1)参与者识别,(2)提供者意识/资源,(3)重点研究人员干预,(4)以患者和社区为重点的意识策略,以及(5)以参与者为导向的资源。13 项研究的招募接受率超过 30%。8 项接受率≥50%的研究报告实施了≥5 项策略,平均在多个类别中使用了 7 项策略。5 项接受率≥50%的研究实施了≥3 个类别的策略。4 项研究报告的保留率≥74%。3 项报告的保留率≥74%的研究使用了≥3 个类别的策略,所有研究都采用了旨在满足参与者在研究之外需求的策略。我们的结果表明,许多旨在增加黑人参与者入组 CCT 的努力具有很大的潜力,但最有前途的策略是采用多管齐下的方法。